José Pedro Gil

Has grant

Universidade Nova de Lisboa Instituto de Higiene e Medicina Tropical

Portugal

Research Interests

Explore related searches

Professors in Portugal

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Malaria drug resistance: treatment alternatives and optimization a project strengthening a national reference centre for anti-malarial clinical trials and capacity building in Angola (MALANGO)

Open Date: 2018-08-01

Close Date: 2022-04-30

Grant: Close

Personalizing anti-malaria therapy through hand-held point of care nanotechnology devices

Open Date: 2015-01-01

Close Date: 2017-12-31

Articles (14)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (5)

Pedro Eduardo Ferreira

University of Minho

PORTUGAL

View details

Ignacio Verde

Full Professor

Universidade da Beira Interior

PORTUGAL

View details

Yanka Salazar

Karolinska Institutet

SWEDEN

View details

Maria Isabel Veiga

Karolinska Institutet

SWEDEN

View details

Johan Ursing

Karolinska Institutet Institutionen för klinisk forskning och utbildning Södersjukhuset

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

José Pedro Gil

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (14)

Monoamine oxidase-A (MAO-A) low-expression variants and increased risk of Plasmodium vivax malaria relapses.

Delayed gametocyte clearance in Plasmodium vivax malaria is associated with polymorphisms in the cytochrome P450 reductase (CPR).

Extensive low-density Plasmodium falciparum reservoir in the island of Príncipe, an isolated malaria pre-elimination setting

Alarming Plasmodium falciparum resistance to artemisinin-based combination therapy in Africa: the critical role of the partner drug

Meta-analysis of the global distribution of clinically relevant CYP2C8 alleles and their inferred functional consequences

Ketoconazole increases atovaquone exposure following concomitant administration with Malarone® in healthy subjects

An update on pharmacogenetic factors influencing the metabolism and toxicity of artemisinin-based combination therapy in the treatment of malaria

The Future in Sensing Technologies for Malaria Surveillance: A Review of Hemozoin-Based Diagnosis

Plasmodium falciparum Multidrug Resistance Proteins (pfMRPs)

Monitoring Plasmodium vivax resistance to antimalarials: Persisting challenges and future directions

Challenges and Opportunities for Clinical Pharmacogenetic Research Studies in Resource-limited Settings: Conclusions From the Council for International Organizations of Medical Sciences–Ibero-American Network of Pharmacogenetics and Pharmacogenomics Meeting

Expansion of a Specific Plasmodium falciparum PfMDR1 Haplotype in Southeast Asia with Increased Substrate Transport

<p>Prevalence of <em>CYP2C82</em> and <em>3</em> among Eritreans and its Potential Impact on Artesunate/Amodiaquine Treatment</p>

Different Plasmodium falciparum clearance times in two Malian villages following artesunate monotherapy

Collaborators (5)

Pedro Eduardo Ferreira

Ignacio Verde

Yanka Salazar

Maria Isabel Veiga

Johan Ursing

Make your next move.

José Pedro Gil

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (14)

Monoamine oxidase-A (MAO-A) low-expression variants and increased risk of Plasmodium vivax malaria relapses.

Delayed gametocyte clearance in Plasmodium vivax malaria is associated with polymorphisms in the cytochrome P450 reductase (CPR).

Extensive low-density Plasmodium falciparum reservoir in the island of Príncipe, an isolated malaria pre-elimination setting

Alarming Plasmodium falciparum resistance to artemisinin-based combination therapy in Africa: the critical role of the partner drug

Meta-analysis of the global distribution of clinically relevant CYP2C8 alleles and their inferred functional consequences

Ketoconazole increases atovaquone exposure following concomitant administration with Malarone® in healthy subjects

An update on pharmacogenetic factors influencing the metabolism and toxicity of artemisinin-based combination therapy in the treatment of malaria

The Future in Sensing Technologies for Malaria Surveillance: A Review of Hemozoin-Based Diagnosis

Plasmodium falciparum Multidrug Resistance Proteins (pfMRPs)

Monitoring Plasmodium vivax resistance to antimalarials: Persisting challenges and future directions

Challenges and Opportunities for Clinical Pharmacogenetic Research Studies in Resource-limited Settings: Conclusions From the Council for International Organizations of Medical Sciences–Ibero-American Network of Pharmacogenetics and Pharmacogenomics Meeting

Expansion of a Specific Plasmodium falciparum PfMDR1 Haplotype in Southeast Asia with Increased Substrate Transport

<p>Prevalence of <em>CYP2C8*2</em> and <em>*3</em> among Eritreans and its Potential Impact on Artesunate/Amodiaquine Treatment</p>

Different Plasmodium falciparum clearance times in two Malian villages following artesunate monotherapy

Collaborators (5)

Pedro Eduardo Ferreira

Ignacio Verde

Yanka Salazar

Maria Isabel Veiga

Johan Ursing

Make your next move.

<p>Prevalence of <em>CYP2C82</em> and <em>3</em> among Eritreans and its Potential Impact on Artesunate/Amodiaquine Treatment</p>